Gains (losses) from operating activities in the statement of income by function of expenses, included according to their nature (Details 7) - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9	$ (2,967)	$ 8,038	$ 7,198
Investments In Associates [Member]
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9	$ 2,967	$ (8,038)	$ (7,198)

The amount of impairment loss, impairment gain or reversal of impairment loss that is recognised in profit or loss in accordance with paragraph 5.5.8 of IFRS 9 and that arises from applying the impairment requirements in Section 5.5 of IFRS 9.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2018-01-01
-Paragraph 82
-Subparagraph ba
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2018-03-01&anchor=para_82_ba&doctype=Standard
-URIDate 2018-03-16

Name:	ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration